by asampaio | Oct 17, 2024 | Uncategorized
We are thrilled to announce our multi-regional licensing agreement with Energenesis Biomedical for the innovative treatment ENERGI-F703DFU, currently in Phase III trials for diabetic foot ulcers (DFU). This partnership marks a significant step in our mission to...
by asampaio | Oct 7, 2024 | Uncategorized
Pharma Bavaria will be attending CPHI in Milan, Italy, from October 8-10, 2024! We look forward to connecting with all our valued partners and exploring new opportunities.
